Alethea Capital Management »

Immuneering Corp - Class A shares owned by Alethea Capital Management

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Alethea Capital Management from 13F filings

Historical chart of Alethea Capital Management investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Alethea Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Alethea Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $161k 23k 7.00
2025-06-30 $77k 23k 3.37

More positions owned by Alethea Capital Management

Axsome Therapeutics (AXSM)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Avidity Biosciences Ord (RNA)
Kura Oncology Call Option (KURA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Johnson & Johnson (JNJ)
Cidara Therapeutics Com New (CDTX)
Ventas (VTR)
UnitedHealth (UNH)
Smucker J M Com New (SJM)
CenterPoint Energy (CNP)
McDonald's Corporation (MCD)
Exelon Corporation (EXC)
Verizon Communications (VZ)
Brown Forman Corp CL B (BF.B)

View all positions for Alethea Capital Management

Top funds holding Immuneering Corp - Class A

FMR
Sanofi
Vanguard Group
ExodusPoint Capital Management
Logos Global Management
Citadel Advisors
BlackRock
Blue Owl Capital Holdings
Geode Capital Management
Monashee Investment Management
Burkehill Global Management
Iridian Asset Management
Southport Management
Marshall Wace
Diametric Capital

View all funds holding Immuneering Corp - Class A